First Finance Ltd. - 04 Aug 2026 Form 4 Insider Report for CLEARONE INC (CLRO)

Reporting relationship: 10%+ Owner
Issuer ticker: CLRO
Reported as of: 04 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Aug 2026, 19:44:18 UTC
Prior SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Hromyk Authorized Signatory of First Finance Ltd.

Key filing fact

First Finance Ltd. filed Form 4 for CLEARONE INC (CLRO) on 06 Aug 2026.

Key facts

This page summarizes First Finance Ltd.'s Form 4 filing for CLEARONE INC (CLRO).
1 reported transaction and 2 derivative rows are listed below.
Accepted by SEC: 06 Aug 2026, 19:44.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0002057383 Primary reporting owner

First Finance Ltd.

Relationship: 10%+ Owner
Address: 520 NEWPORT CENTER DRIVE,, SUITE 650, NEWPORT BEACH
Signature: /s/ Andrew Hromyk Authorized Signatory of First Finance Ltd.
Signature date: 06 Aug 2026

CIK 0001145688

HROMYK ANDREW

Relationship: 10%+ Owner
Address: 520 NEWPORT CENTER DRIVE,, SUITE 650, NEWPORT BEACH
Signature: /s/ Andrew Hromyk
Signature date: 06 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLRO transaction Derivative

Common Stock Purchase Warrant

Other

Transaction value
Shares: -437,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 437,500
Exercise price: $5.00
Footnotes: F1

CLRO transaction Derivative

Common Stock Purchase Warrant

Other

Transaction value
Shares: -437,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 437,500
Exercise price: $5.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On August 4, 2026, pursuant to the Agreement and Plan of Merger by and among ClearOne, Inc. (the "Issuer"), CLRO Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"), Cortigent, Inc. ("Cortigent"), and Vivani Medical, Inc., pursuant to which Merger Sub will merge with and into Cortigent, with Cortigent surviving as a wholly-owned subsidiary of the Issuer, First Finance Ltd. entered into a Warrant Cancellation Agreement with the Issuer pursuant to which First Finance Ltd. surrendered and cancelled the Common Stock Purchase Warrant in its entirety for no consideration. As a result of the Warrant Cancellation Agreement, First Finance Ltd. no longer holds any derivative securities of the Issuer. The Common Stock Purchase Warrant was exercisable six months from the original closing date (March 6, 2026) and was set to expire two years from the closing date.